Related Experiment Video
Updated: Jun 13, 2025

05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.5K
Targeted protein degradation: current molecular targets, localization, and strategies
Dimanthi Pliatsika1, Cindy Blatter1, Rainer Riedl1
1Institute of Chemistry and Biotechnology, Competence Center for Drug Discovery, Zurich University of Applied Sciences, CH-8820 Wädenswil, Switzerland.
Drug Discovery Today
|September 14, 2024
Summary
Targeted protein degradation (TPD) is transforming drug discovery by eliminating specific proteins. This review explores TPD
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Drug Discovery
- Cell Biology
Background:
- Targeted protein degradation (TPD) has emerged as a powerful therapeutic modality.
- Initially focused on intracellular targets, TPD's scope has broadened significantly.
- The field has evolved over two decades, expanding beyond cancer therapeutics.
Purpose of the Study:
- To review the expanding landscape of targeted protein degradation.
- To highlight novel protein targets beyond traditional applications.
- To discuss strategies for targeting challenging protein locations like the extracellular matrix and membranes.
Main Methods:
- Comprehensive literature review of recent advancements in TPD.
- Analysis of TPD strategies applied to diverse protein targets.
- Examination of TPD applications in various disease contexts.
Main Results:
- TPD is increasingly applied to a wider range of proteins and diseases.
- Targeting extracellular matrix and membrane proteins presents new opportunities and challenges.
- Innovative TPD strategies are being developed for difficult-to-drug targets.
Conclusions:
- TPD holds immense potential for treating various diseases by targeting diverse proteins.
- Overcoming challenges in targeting extracellular and membrane proteins is crucial for future TPD development.
- This review provides insights into the evolving strategies and future directions in TPD for drug discovery.
Related Concept Videos
Regulated Protein Degradation
2.5K
2.5K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Directing Proteins to the Rough Endoplasmic Reticulum
7.2K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
7.2K

